Nonetheless, there are differences in clinical efficacies of these drugs and some are also able to reduce body weight in obese patients, improve cardiovascular outcomes, and may have benefit for the treatment of neurodegenerative disorders (Brown et al., 2018
doi: 10.3389/fonc.2023.1099811
The MHRAs chief safety officer, Dr Alison Cave, said: While the potential risk of NAION for patients prescribed semaglutide is extremely small, it is important that patients and healthcare professionals are alert to the associated symptoms. Privately prescribed semaglutide may not appear on a patients medical history so if a patient presents with these symptoms, healthcare professionals should enquire about semaglutide use
Discover a personalized, physician-led path to sustainable weight loss right here in Coral Springs
(Sun F et coll
The mortality rate associated with cocaine overdose is also increasing rapidly worldwide, exceeding opioid overdose-related deaths
